| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c6107abcc76ad54b3821249d6315e0ab |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-551
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-609
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-616
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-60 |
| filingDate |
2003-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd7b73c7bdfb44d0db7b815b80c43392
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f66f7928378d9a6e26d4a3337bf738b5 |
| publicationDate |
2004-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2004231597-A |
| titleOfInvention |
Pharmaceutical preparations |
| abstract |
The present invention provides a pharmaceutical preparation having an enhanced antipyretic analgesic effect. The combined use of emedastine or a salt thereof and a salicylic acid anti-inflammatory drug enhances the antipyretic analgesic effect. Thereby, a highly safe pharmaceutical preparation having an excellent analgesic effect can be obtained. [Selection diagram] None |
| priorityDate |
2003-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |